核技术
覈技術
핵기술
NUCLEAR TECHNIQUES
2009年
8期
620-625
,共6页
杨晓春%申咏梅%石怡珍%谢小芳
楊曉春%申詠梅%石怡珍%謝小芳
양효춘%신영매%석이진%사소방
淋巴瘤%B细胞%抗体%碘-131%放射免疫治疗%磁共振
淋巴瘤%B細胞%抗體%碘-131%放射免疫治療%磁共振
림파류%B세포%항체%전-131%방사면역치료%자공진
Lyrnphoma%B-cell%Antibodies%Iodine-131%Radioimmunotreatment%Magnetic resonance imaging
将荷人B细胞淋巴瘤裸鼠分为对照组、Fab抗体组、单次注射组和重复注射组,尾静脉注射131Ⅰ-Fab抗体后进行ECT显像;每隔5 d用MRI结合显微镜线圈检测荷瘤裸鼠的肿瘤大小.注射后25 d,取出肿瘤,进行病理分析、流式细胞术和电镜检测细胞凋亡.结果显示,131Ⅰ-Fab抗体静脉注射后8 h在肿瘤局部浓集明显,瘤体清晰显像;Fab组5 d内具有抑制肿瘤生长作用,凋亡率为(2.48±0.6)%;单次131Ⅰ-Fab注射组早期抑制肿瘤生长较明显,肿瘤生长出现平台期,凋亡率为(10.67±1.6)%;131Ⅰ-Fab抗体重复注射组抑制肿瘤生长作用明显,肿瘤局部坏死脱落,凋亡率为(14.00±1.9)%.病理结果显示两注射组均可见组织坏死.MRI图像与病理结果相符,通过造影剂增强可提供较准确的病理信息.表明131Ⅰ-Fab抗体具有早期ECT肿瘤显像、瘤体准确定位,并通过致凋亡和直接促使细胞死亡的作用而有效抑制肿瘤生长,大型高场强MRI可为小动物模型实验提供有效、无创、动态的监测.
將荷人B細胞淋巴瘤裸鼠分為對照組、Fab抗體組、單次註射組和重複註射組,尾靜脈註射131Ⅰ-Fab抗體後進行ECT顯像;每隔5 d用MRI結閤顯微鏡線圈檢測荷瘤裸鼠的腫瘤大小.註射後25 d,取齣腫瘤,進行病理分析、流式細胞術和電鏡檢測細胞凋亡.結果顯示,131Ⅰ-Fab抗體靜脈註射後8 h在腫瘤跼部濃集明顯,瘤體清晰顯像;Fab組5 d內具有抑製腫瘤生長作用,凋亡率為(2.48±0.6)%;單次131Ⅰ-Fab註射組早期抑製腫瘤生長較明顯,腫瘤生長齣現平檯期,凋亡率為(10.67±1.6)%;131Ⅰ-Fab抗體重複註射組抑製腫瘤生長作用明顯,腫瘤跼部壞死脫落,凋亡率為(14.00±1.9)%.病理結果顯示兩註射組均可見組織壞死.MRI圖像與病理結果相符,通過造影劑增彊可提供較準確的病理信息.錶明131Ⅰ-Fab抗體具有早期ECT腫瘤顯像、瘤體準確定位,併通過緻凋亡和直接促使細胞死亡的作用而有效抑製腫瘤生長,大型高場彊MRI可為小動物模型實驗提供有效、無創、動態的鑑測.
장하인B세포림파류라서분위대조조、Fab항체조、단차주사조화중복주사조,미정맥주사131Ⅰ-Fab항체후진행ECT현상;매격5 d용MRI결합현미경선권검측하류라서적종류대소.주사후25 d,취출종류,진행병리분석、류식세포술화전경검측세포조망.결과현시,131Ⅰ-Fab항체정맥주사후8 h재종류국부농집명현,류체청석현상;Fab조5 d내구유억제종류생장작용,조망솔위(2.48±0.6)%;단차131Ⅰ-Fab주사조조기억제종류생장교명현,종류생장출현평태기,조망솔위(10.67±1.6)%;131Ⅰ-Fab항체중복주사조억제종류생장작용명현,종류국부배사탈락,조망솔위(14.00±1.9)%.병리결과현시량주사조균가견조직배사.MRI도상여병리결과상부,통과조영제증강가제공교준학적병리신식.표명131Ⅰ-Fab항체구유조기ECT종류현상、류체준학정위,병통과치조망화직접촉사세포사망적작용이유효억제종류생장,대형고장강MRI가위소동물모형실험제공유효、무창、동태적감측.
Nude mice bearing human B cell lymphoma were divided into four groups: control,Fab antibody,single injection and duplication injection.Radioimmunoimages were taken after injection with 131Ⅰ-labeled Fab antibody through tail vein.The cancer-bearing mice were detected by MRI combined with microscopy coil every 5 days,and tumor sizes were measured.On the 25th day after injection,the tumors were taken out for pathology and apoptosis analysis by flow cytomctry (FCM) and TEM,respectively.The results of ECT showed that radioactive nuclide enriched in the area of the tumor obviously at 8 hour after injection,and the mass could be displayed clearly.The growth suppression effect could be displayed in 5 days in Fab antibody group and the apoptotic rate was (2.48±0.6)%.The growth suppression effect was obvious in the prophase in single injection group,and the plateau phase could be seen in the tumor growth curve,with the apoptotic rate of (10.67±1.6)%.The growth suppression effect was more obvious in duplication injection group and the local tissues of tumor necrosed and fallen off,with the apoptotic rate of (14.00±1.9)%.The pathologic results showed tissue necroses in both single group and duplication injection group.The MRI image conformed to the results of pathology,and could provide accurate pathology information by contrast medium enhancement,131Ⅰ labeled Fab antibody against B cell lymphoma can image the tumor early through ECT,locate the tumor mass accurately and suppress tumor growth through the mechanism of apoptosis and cell death.It can be a kind of potential and effective bioengineering medicine to neat the tumor in the area of radioimmunothcrapy.Large high field MRI can provide effective,atranmatic and dynamic detection to the little animal model,and have wide application for little animal model.